Searched over 200M research papers
2 papers analyzed
These studies suggest that statins are not associated with an increased likelihood of constipation and may even improve symptoms in some cases.
18 papers analyzed
Statins are widely prescribed medications primarily used to lower cholesterol levels and reduce the risk of cardiovascular diseases. However, like all medications, they come with potential side effects. Among these, gastrointestinal issues such as constipation, abdominal pain, and diarrhea have been reported. This article explores whether statins are associated with constipation based on recent research findings.
A comprehensive retrospective cohort study examined the association between statin therapy and various lower gastrointestinal conditions, including constipation. The study analyzed data from a regional military healthcare system, comparing 6,342 statin users with an equal number of non-users. The primary outcomes measured were the odds ratios for diagnoses of constipation, abdominal pain, diarrhea, and colitis, among others.
The findings revealed no statistically significant difference in the incidence of constipation between statin users and non-users (OR, 0.96; 95% CI, 0.87–1.05; P = .33). This suggests that statin therapy does not significantly increase the likelihood of experiencing constipation.
Interestingly, another study focused on the effects of lovastatin, a specific type of statin, on irritable bowel syndrome with constipation (IBS-C). The research highlighted that methane production by the methanoarchaeon Methanobrevibacter smithii is linked to constipation and IBS-C. Lovastatin, particularly in its lactone form, was found to inhibit enzymes in the methanogenesis pathway of these archaea, potentially reducing methane levels and alleviating constipation symptoms.
This study's findings were supported by a phase II clinical trial, which demonstrated that a modified-release lovastatin-lactone (SYN-010) reduced symptoms and breath methane levels in patients with IBS-C compared to a placebo. Thus, lovastatin may have a beneficial effect on constipation in specific contexts, particularly related to IBS-C.
In summary, the evidence suggests that statins, in general, do not significantly increase the risk of constipation. However, lovastatin, a specific type of statin, may actually help alleviate constipation symptoms in patients with IBS-C by inhibiting methane production. Therefore, while statins are not broadly associated with causing constipation, certain formulations like lovastatin-lactone could offer therapeutic benefits for constipation in specific conditions.
Most relevant research papers on this topic